Search results for " Tumor."

showing 10 items of 3792 documents

Neuroendocrine tumor of the common bile duct: case report

2017

Neuroendocrine tumors (NET) are a very heterogeneous group of neoplasms; in recent years we have seen an increase in their incidence (3.65 /100.000/year). They can be associated with hereditary endocrine syndromes (MEN, Von Hippel Lindau); they can occur at any age and the incidence is slightly higher in men than women. The aetiology of the neuroendocrine tumors is unclear; in most cases, inflammation of the bile ducts may be the underlying cause and for this reason, the initial patient's evaluation should be focused on the different aspects concerning the oncological one and the possible sequelae of the biliary obstructions that can evolve in biliary sepsis. All neuroendocrine tumors have …

medicine.medical_specialtyChromogranin A; Neuroendocrine tumor of the common hepatic duct; SurgeryeducationCommon Bile Duct Neoplasms030230 surgeryNeuroendocrine tumorsGastroenterologyClinical Practice03 medical and health sciencesDistal Common Bile Duct0302 clinical medicineInternal medicinemedicineHumansCommon bile ductbusiness.industryBile ductGeneral surgeryNeuroendocrine tumor of the common hepatic ductJaundiceMiddle Agedmedicine.diseaseNeuroendocrine Tumorsmedicine.anatomical_structureCommon hepatic ductBiliary tract030220 oncology & carcinogenesisCystic ductChromogranin Apopulation characteristicsSurgeryFemalemedicine.symptombusiness
researchProduct

GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis

2020

Background & Aims The prevalence of nonalcoholic steatohepatitis (NASH) associated hepatocellular carcinoma (HCC) is increasing. However, strategies for detection of early-stage HCC in patients with NASH have limitations. We assessed the ability of the GALAD score, which determines risk of HCC based on patient sex; age; and serum levels of α-fetoprotein (AFP), AFP isoform L3 (AFP-L3), and des-gamma-carboxy prothrombin (DCP), to detect HCC in patients with NASH. Methods We performed a case-control study of 125 patients with HCC (20% within Milan Criteria) and 231 patients without HCC (NASH controls) from 8 centers in Germany. We compared the performance of serum AFP, AFP-L3, or DCP vs GALAD …

medicine.medical_specialtyCirrhosisCarcinoma HepatocellularMedizinPilot ProjectsMilan criteriaGastroenterologySensitivity and SpecificityCohort Studies03 medical and health sciences0302 clinical medicineNon-alcoholic Fatty Liver DiseaseInternal medicinemedicineBiomarkers TumorHumansProtein PrecursorsneoplasmsHepatologyReceiver operating characteristicbusiness.industryLiver NeoplasmsGastroenterologyArea under the curvemedicine.diseasedigestive system diseasesROC Curve030220 oncology & carcinogenesisHepatocellular carcinomaCase-Control StudiesCohort030211 gastroenterology & hepatologyProthrombinalpha-FetoproteinsbusinessLiver cancerBiomarkersCohort study
researchProduct

A methodological framework to enhance the clinical success of cancer immunotherapy.

2011

medicine.medical_specialtyClinical Trials as Topicbusiness.industrymedicine.medical_treatmentPublicationsBiomedical EngineeringBioengineeringGuidelines as TopicApplied Microbiology and BiotechnologyClinical successSurvival AnalysisText miningTreatment OutcomeCancer immunotherapyNeoplasmsBiomarkers TumorMolecular MedicineMedicineHumansMedical physicsCTLA-4 AntigenImmunotherapybusinessBiotechnologyNature biotechnology
researchProduct

Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers

2015

AbstractFluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) has become a routine imaging modality for many malignancies and its use is currently increasing. In the present review article, we will summarize the evidence for FDG-PET/CT use in digestive cancers (excluding neuroendocrine tumours), and review the existing recommendations. While PET/CT is nowadays considered to be an important tool in the initial workup of oesophageal and anal cancers, new data are emerging regarding its use in assessing therapeutic efficacy, radiotherapy treatment planning, and detection of recurrence in case of isolated tumour marker elevation. Moreover, PET/CT may help …

medicine.medical_specialtyColorectal cancerColonoscopyDigestive System NeoplasmsMultimodal ImagingPatient Care PlanningFluorodeoxyglucose positron emission tomographyFluorodeoxyglucose F18Pancreatic cancerHumansMedicinePositron Emission Tomography-Computed TomographyFluorine-18-fluorodeoxyglucoseHepatologymedicine.diagnostic_testbusiness.industryOesophageal cancerGastroenterologyPancreatic cancerRadiotherapy treatment planningPrognosismedicine.diseaseColorectal cancerFDG-PET/CTAnal canal cancerReview articleNeuroendocrine TumorsPositron-Emission TomographyPractice Guidelines as TopicRadiologyNeoplasm Recurrence LocalRadiopharmaceuticalsTomography X-Ray ComputedbusinessDigestive and Liver Disease
researchProduct

Neuro-radiosurgery treatments: MRI brain tumor seeded image segmentation based on a cellular automata model

2016

Gross Tumor Volume (GTV) segmentation on medical images is an open issue in neuro-radiosurgery. Magnetic Resonance Imaging (MRI) is the most promi-nent modality in radiation therapy for soft-tissue anatomical districts. Gamma Knife stereotactic neuro-radiosurgery is a mini-invasive technique used to deal with inaccessible or insufficiently treated tumors. During the planning phase, the GTV is usually contoured by radiation oncologists using a manual segmentation procedure on MR images. This methodology is certainly time-consuming and op-erator-dependent. Delineation result repeatability, in terms of both intra- and inter-operator reliability, is only obtained by using computer-assisted appr…

medicine.medical_specialtyComputer sciencemedicine.medical_treatment02 engineering and technologyCellular AutomataBrain tumors; Cellular automata; Gamma knife treatments; MR imaging; Semi-automatic segmentationBrain tumorsRadiosurgery030218 nuclear medicine & medical imagingTheoretical Computer Science03 medical and health sciences0302 clinical medicineGamma Knife treatments0202 electrical engineering electronic engineering information engineeringmedicineSegmentationMri brainModality (human–computer interaction)medicine.diagnostic_testSemi-automatic segmentationbusiness.industryINF/01 - INFORMATICAMagnetic resonance imagingImage segmentationCellular automatonRadiation therapyBrain tumor020201 artificial intelligence & image processingGamma Knife treatmentArtificial intelligenceRadiologybusinessMR imaging
researchProduct

Head–Neck Cancer Delineation

2021

Head–Neck Cancer (HNC) has a relevant impact on the oncology patient population and for this reason, the present review is dedicated to this type of neoplastic disease. In particular, a collection of methods aimed at tumor delineation is presented, because this is a fundamental task to perform efficient radiotherapy. Such a segmentation task is often performed on uni-modal data (usually Positron Emission Tomography (PET)) even though multi-modal images are preferred (PET-Computerized Tomography (CT)/PET-Magnetic Resonance (MR)). Datasets can be private or freely provided by online repositories on the web. The adopted techniques can belong to the well-known image processing/computer-vision a…

medicine.medical_specialtyComputer sciencemedicine.medical_treatmentImage processinghead–neck cancer (HNC)Head neck cancerlcsh:Technology030218 nuclear medicine & medical imagingTask (project management)head and neck squamous cell carcinoma (HNSCC)lcsh:Chemistry03 medical and health sciencestumor delineation0302 clinical medicinemedicineGeneral Materials ScienceMedical physicsSegmentationlcsh:QH301-705.5InstrumentationSettore ING-INF/05 - Sistemi Di Elaborazione Delle InformazioniFluid Flow and Transfer Processesmedicine.diagnostic_testlcsh:Tbusiness.industryProcess Chemistry and TechnologyDeep learningsegmentationGeneral EngineeringCT Head and neck squamous cell carcinoma (HNSCC) Head–neck cancer (HNC) MRI Nasopharyngeal cancer (NPC) PET Segmentation Tumor delineationnasopharyngeal cancer (NPC)lcsh:QC1-999Computer Science ApplicationsRadiation therapylcsh:Biology (General)lcsh:QD1-999lcsh:TA1-2040Positron emission tomography030220 oncology & carcinogenesisArtificial intelligenceTomographylcsh:Engineering (General). Civil engineering (General)businesslcsh:PhysicsCTApplied Sciences
researchProduct

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (…

2015

ABSTRACT The DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) aims to provide recommendations for definitions of time-to-event end points in cancer randomized controlled trials. We relied on a consensus method based on a multidisciplinary panel of experts to develop these guidelines for trials on sarcomas and gastrointestinal stromal tumors. Background The use of potential surrogate end points for overall survival, such as disease-free survival (DFS) or time-to-treatment failure (TTF) is increasingly common in randomized controlled trials (RCTs) in cancer. However, the definition of time-to-event (TTE) end points is rarely precise and lacks unif…

medicine.medical_specialtyConsensusTime FactorssarcomaDelphi TechniqueEndpoint Determination[SDV]Life Sciences [q-bio]Disease-Free Survivallaw.invention03 medical and health sciencesgastrointestinal stromal tumors0302 clinical medicineRandomized controlled trialSDG 3 - Good Health and Well-beinglawMultidisciplinary approachTerminology as TopicmedicineHumansMedical physicsTreatment Failureguidelinestime-to-event end pointComputingMilieux_MISCELLANEOUSRandomized Controlled Trials as Topic030304 developmental biologyEvent (probability theory)0303 health sciencesEnd pointGiSTSurrogate endpointbusiness.industryefficacy measureCancerHematologymedicine.disease3. Good healthOncologyResearch Design030220 oncology & carcinogenesisrandomized controlled trialDisease ProgressionRadiologySarcomabusiness
researchProduct

Radiomics and radiogenomics in head and neck squamous cell carcinoma: Potential contribution to patient management and challenges

2021

Abstract The application of imaging biomarkers in oncology is still in its infancy, but with the expansion of radiomics and radiogenomics a revolution is expected in this field. This may be of special interest in head and neck cancer, since it can promote precision medicine and personalization of treatment by overcoming several intrinsic obstacles in this pathology. Our goal is to provide the medical oncologist with the basis to approach these disciplines and appreciate their main uses in clinical research and clinical practice in the medium term. Aligned with this objective we analyzed the most relevant studies in the field, also highlighting novel opportunities and current challenges.

medicine.medical_specialtyDecision MakingRadiogenomicsPersonalizationMedium termMachine LearningRadiomicsBiomarkers TumormedicineHumansRadiology Nuclear Medicine and imagingMedical physicsPrecision MedicineSquamous Cell Carcinoma of Head and Neckbusiness.industryHead and neck cancerGeneral MedicinePrognosismedicine.diseasePrecision medicineHead and neck squamous-cell carcinomaPatient managementOncologyHead and Neck NeoplasmsbusinessDiagnostic Techniques RadioisotopeCancer Treatment Reviews
researchProduct

Accuracy of computer-aided image analysis in the diagnosis of odontogenic cysts: A systematic review

2020

Background This study aimed to search for scientific evidence concerning the accuracy of computer-assisted analysis for diagnosing odontogenic cysts. Material and Methods A systematic review was conducted according to the PRISMA statements and considering eleven databases, including the grey literature. Protocol was registered in PROSPERO (CRD 42020189349). The PECO strategy was used to define the eligibility criteria and only studies involving diagnostic accuracy were included. Their risk of bias was investigated using the Joanna Briggs Institute Critical Appraisal tool. Results Out of 437 identified citations, five papers, published between 2006 and 2019, fulfilled the criteria and were i…

medicine.medical_specialtyDentigerous CystMEDLINEOdontogenic TumorsReviewmelanomamedicineGlandular odontogenic cystHumansKeratocystGeneral DentistryUNESCO:CIENCIAS MÉDICASRadicular CystRadicular CystOral Medicine and Pathologyoral mucosabusiness.industryComputersLateral periodontal cystmedicine.diseaseoral melanomaDentigerous cystCritical appraisalOtorhinolaryngologyMeta-analysisOdontogenic Cystshead and neck cancerSurgeryRadiologymedicine.symptombusinessMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

A case report of desmoplastic ameloblastoma

2010

Ameloblastomas are the most common benign neoplasm of odontogenic nature. Desmoplastic ameloblastoma (DA) was included in the World Health Organization Classification of Head and Neck Tumors (WHO-2005) as a variant of ameloblastoma with specific clinical, image, and histological features. This case report focuses on a DA which occurred in the mandible of a 25 year-old man. The main signals and symptoms included painless swelling with buccal expansion and tooth displacement. Panoramic and periapical radiographs and cone-bean computed to- mography demonstrated an image mimicking a benign fibro-osseous lesion. The lower border of the mandible was not involved, but tooth displacement could be o…

medicine.medical_specialtyDesmoplastic ameloblastomabusiness.industryHead and neck tumorsMandibleOdontología:CIENCIAS MÉDICAS [UNESCO]Marginal resectionmedicine.diseaseCiencias de la saludWorld healthSurgeryLesionstomatognathic diseasesUNESCO::CIENCIAS MÉDICASmedicineDisplacement (orthopedic surgery)medicine.symptombusinessAmeloblastomaGeneral DentistryJournal of Clinical and Experimental Dentistry
researchProduct